Padovano William M, Skolnick Gary B, Naidoo Sybill D, Snyder-Warwick Alison K, Patel Kamlesh B
Division of Plastic and Reconstructive Surgery, 12275Washington University in St. Louis School of Medicine, MO, USA.
Cleft Palate Craniofac J. 2022 Apr;59(4):462-474. doi: 10.1177/10556656211009702. Epub 2021 Apr 22.
The aim of this systematic review and meta-analysis was to investigate long-term treatment effects of nasoalveolar molding (NAM) in patients with unilateral cleft lip and palate (UCLP).
Included manuscripts met the following criteria: (1) involved patients with UCLP who received NAM; (2) included comparison group(s) who either received non-NAM passive presurgical infant orthopedic appliances (PSIO) or who did not receive any PSIO; (3) reported at least one objective or validated measure of nasolabial, craniofacial, or palatal form; and (4) had patient follow-up beyond 4 years of age.
A total of 12 studies were included in this review. Meta-analyses were possible for Asher-McDade parameters and cephalometric measurements. Compared to patients who did not receive any PSIO, those who underwent NAM therapy were more likely to have good to excellent frontal nasal form (Risk ratio: 2.4, 95% CI: 1.24-3.68) and vermillion border (Risk ratio: 1.8, 95% CI: 1.19-2.71). However, there were no statistically significant differences in cephalometric measurements between these groups. Additionally, there were no statistically significant differences between patients receiving NAM versus non-NAM PSIO. There was insufficient evidence to determine the impact of NAM on dental arch development.
The preponderance of evidence in this review suggests that NAM produces benefits in nasolabial aesthetic form when compared with no appliance-based presurgical treatment. However, there is insufficient evidence to conclude whether NAM produces such benefits when compared with other passive PSIOs.
本系统评价和荟萃分析的目的是研究鼻牙槽塑形(NAM)对单侧唇腭裂(UCLP)患者的长期治疗效果。
纳入的手稿符合以下标准:(1)涉及接受NAM治疗的UCLP患者;(2)包括接受非NAM被动术前婴儿矫形器(PSIO)或未接受任何PSIO的对照组;(3)报告至少一项鼻唇、颅面或腭部形态的客观或经过验证的测量指标;(4)患者随访至4岁以后。
本评价共纳入12项研究。对阿舍-麦克戴德参数和头影测量进行荟萃分析。与未接受任何PSIO的患者相比,接受NAM治疗的患者更有可能获得良好至优秀的额鼻形态(风险比:2.4,95%置信区间:1.24-3.68)和唇红缘(风险比:1.8,95%置信区间:1.19-2.71)。然而,这些组之间的头影测量无统计学显著差异。此外,接受NAM与非NAM PSIO的患者之间也无统计学显著差异。没有足够的证据来确定NAM对牙弓发育的影响。
本评价中的大量证据表明,与不进行基于矫治器的术前治疗相比,NAM在鼻唇美学形态方面有好处。然而,没有足够的证据来得出与其他被动PSIO相比NAM是否能产生此类益处的结论。